Cargando…
Targeting cell cycle regulators in hematologic malignancies
Hematologic malignancies represent the fourth most frequently diagnosed cancer in economically developed countries. In hematologic malignancies normal hematopoiesis is interrupted by uncontrolled growth of a genetically altered stem or progenitor cell (HSPC) that maintains its ability of self-renewa...
Autores principales: | Aleem, Eiman, Arceci, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390903/ https://www.ncbi.nlm.nih.gov/pubmed/25914884 http://dx.doi.org/10.3389/fcell.2015.00016 |
Ejemplares similares
-
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
por: Bhardwaj, Vaishali, et al.
Publicado: (2023) -
P2X7 Receptor in Hematological Malignancies
por: De Marchi, Elena, et al.
Publicado: (2021) -
Editorial: Non-cell Cycle Functions of Cell Cycle Regulators
por: Liu, Song-Tao, et al.
Publicado: (2019) -
Cell Cycle Commitment and the Origins of Cell Cycle Variability
por: Brooks, Robert F.
Publicado: (2021) -
Regulated Cell Death in Urinary Malignancies
por: Nie, Zhenyu, et al.
Publicado: (2021)